RecruitingNot Applicable

Lupus Landmark Study: A Prospective Registry and Biorepository

United States3,500 participantsStarted 2023-06-28

Plain-language summary

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

Who can participate

Age range18 Years – 110 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Able to understand and comply with study procedures and voluntarily sign a written informed consent document * Age 18 years or older at the time of enrollment * Fulfill criteria for SLE based on one or more of the following classifications systems: Systemic Lupus Erythematosus International Collaborating Clinic (SLICC) 2012 criteria; European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 criteria; 1997 revised ACR criteria; or Lupus is present per clinical assessment. Exclusion Criteria: * Not able to obtain consent * Not able to meet protocol visit requirements * Pregnant at the time of enrollment

What they're measuring

Identify genetic drivers and antigenic targets, to elucidate mechanistic heterogeneity and correlate biomarkers to therapeutic responses.

Timeframe: up to 25 years

Trial details

NCT IDNCT05934149

SponsorLupus Research Alliance

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2035-12

Contact for this trial

Lupus Nexus Director

646-884-6084 lupusnexus@lupusresearch.org

View on ClinicalTrials.gov More Systemic Lupus Erythematosus (SLE) trials